NDC 0031-9304
Robitussin Direct Runny Nose
Diphenhydramine
Robitussin Direct Runny Nose is a Oral Tablet, Coated in the Human Otc Drug category. It is labeled and distributed by Glaxosmithkline Consumer Healthcare Holdings (us) Llc. The primary component is Diphenhydramine Hydrochloride.
| Product ID | 0031-9304_7a049de2-8f24-4cb3-8b30-331db00a455e |
| NDC | 0031-9304 |
| Product Type | Human Otc Drug |
| Proprietary Name | Robitussin Direct Runny Nose |
| Generic Name | Diphenhydramine |
| Dosage Form | Tablet, Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2022-07-15 |
| Marketing Category | OTC MONOGRAPH FINAL / |
| Application Number | part341 |
| Labeler Name | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
| Substance Name | DIPHENHYDRAMINE HYDROCHLORIDE |
| Active Ingredient Strength | 25 mg/1 |
| Pharm Classes | Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |